Ubs Group Ag Neuro Metrix, Inc. Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.92 - $1.48 $3,001 - $4,827	-3,262 Reduced 81.86%	723 $0
Q1 2023 May 12, 2023	BUY	$1.43 - $2.0 $5,698 - $7,970	3,985 New	3,985 $5,000
Q3 2022 Nov 10, 2022	BUY	$2.97 - $23.6 $8,615 - $68,463	2,901 Added 695.68%	3,318 $9,000
Q2 2022 Aug 10, 2022	BUY	$2.81 - $5.5 $525 - $1,028	187 Added 81.3%	417 $1,000
Q1 2022 May 16, 2022	SELL	$3.42 - $6.37 $745 - $1,388	-218 Reduced 48.66%	230 $1,000
Q4 2021 Feb 14, 2022	SELL	$5.02 - $9.82 $3,177 - $6,216	-633 Reduced 58.56%	448 $2,000
Q3 2021 Nov 15, 2021	SELL	$3.23 - $24.73 $22,180 - $169,820	-6,867 Reduced 86.4%	1,081 $11,000
Q2 2021 Aug 13, 2021	BUY	$2.72 - $3.8 $19,581 - $27,356	7,199 Added 961.15%	7,948 $27,000
Q1 2021 May 12, 2021	SELL	$3.01 - $5.35 $5,237 - $9,309	-1,740 Reduced 69.91%	749 $3,000
Q4 2020 Feb 11, 2021	SELL	$1.5 - $3.64 $4,930 - $11,964	-3,287 Reduced 56.91%	2,489 $8,000
Q3 2020 Nov 12, 2020	BUY	$1.48 - $2.26 $8,548 - $13,053	5,776 New	5,776 $10,000
Q1 2020 May 01, 2020	SELL	$0.86 - $4.75 $1,510 - $8,341	-1,756 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.7 - $5.19 $4,741 - $9,113	1,756 New	1,756 $8,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $30.1M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.